IDBS Receives Prestigious Frost & Sullivan Industry Award

IDBS, a provider of drug discovery data management solutions, has been awarded the 2008 Frost & Sullivan European Bioinformatics Service Differentiation Innovation Award.

Analysts from Frost & Sullivan perform extensive market research in order to determine potential award recipients. Their research indicated that: ‘IDBS provides real value to the life sciences industry through its consulting services.’ By enabling the companies in the life sciences market to integrate research and business data, IDBS is helping organizations to make intelligent business decisions in a market that is characterized by budgetary restrictions and strong competition.

IDBS’ willingness to partner with pharmaceutical and biotechnology companies to achieve scientific and business excellence, and the contribution of its highly skilled staff who possess extensive scientific and IT expertise, were identified as two key differentiators that have helped IDBS achieve an average of 15 per cent growth per year in a highly competitive and fragmented market.

"ID Business Solutions Ltd (IDBS) with its innovative range of product services has demonstrated a strong understanding of the bioinformatics market,” notes Frost & Sullivan analyst E. Sujith. “With a highly service-oriented model, IDBS displays its commitment to give real value to its customers. Beyond its superiority in various product solutions, the range of services catering to the life sciences industry makes IDBS a worthy recipient of this award."

Neil Kipling, founder and CEO of IDBS, commented: "We at IDBS are very honored to be given this prestigious award. We would also like to take this opportunity to thank all our customers for their continued support and loyalty."